Exact Mass: 631.3289

Exact Mass Matches: 631.3289

Found 25 metabolites which its exact mass value is equals to given mass value 631.3289, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   
   

Asp Arg Val Lys Asp

Asp Arg Val Lys Asp

C25H45N9O10 (631.3289)


   

Asn Arg Glu Ser Leu

Asn Arg Glu Ser Leu

C25H45N9O10 (631.3289)


   

Asp Arg Arg Trp

(3S)-3-amino-3-{[(1S)-4-carbamimidamido-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}propanoic acid

C27H41N11O7 (631.319)


   

Asp Arg Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C27H41N11O7 (631.319)


   

Asp Trp Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C27H41N11O7 (631.319)


   

Arg Asp Arg Trp

(3S)-3-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C27H41N11O7 (631.319)


   

Arg Asp Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C27H41N11O7 (631.319)


   

Arg Arg Asp Trp

(3S)-3-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C27H41N11O7 (631.319)


   

Arg Arg Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C27H41N11O7 (631.319)


   

Arg Trp Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C27H41N11O7 (631.319)


   

Arg Trp Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]butanedioic acid

C27H41N11O7 (631.319)


   

Trp Asp Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C27H41N11O7 (631.319)


   

Trp Arg Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C27H41N11O7 (631.319)


   

Trp Arg Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]butanedioic acid

C27H41N11O7 (631.319)


   

DRVKD

Asp-Arg-Val-Lys-Asp

C25H45N9O10 (631.3289)


   
   

ST 22:1;O8;HexNAc

ST 22:1;O8;HexNAc

C30H49NO13 (631.3204)


   

ST 26:5;O5;HexNAc

ST 26:5;O5;HexNAc

C34H49NO10 (631.3356)


   

11-ethyl-5,14-dihydroxy-6,8,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

11-ethyl-5,14-dihydroxy-6,8,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

C34H49NO10 (631.3356)


   

(1s,2r,3r,4s,5r,6s,8r,9r,10r,13r,14r,16s,17s,18r)-11-ethyl-8,14-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 3,4-dimethoxybenzoate

(1s,2r,3r,4s,5r,6s,8r,9r,10r,13r,14r,16s,17s,18r)-11-ethyl-8,14-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 3,4-dimethoxybenzoate

C34H49NO10 (631.3356)


   

(1s,2r,3r,4r,5r,6s,7s,8r,9r,10r,13r,14r,16s,17s,18r)-4-(benzyloxy)-11-ethyl-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate

(1s,2r,3r,4r,5r,6s,7s,8r,9r,10r,13r,14r,16s,17s,18r)-4-(benzyloxy)-11-ethyl-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate

C34H49NO10 (631.3356)


   

3-[(13s)-5,6,9,12,15,16-hexahydroxy-2-oxo-7-[(2e,4e,6e)-pentadeca-2,4,6,14-tetraen-1-yl]-3h,3ah,6h,7h,10h,13h,16h,16ah-furo[3,2-l]1,4,7,11-tetraazacyclopentadecan-13-yl]propanimidic acid

3-[(13s)-5,6,9,12,15,16-hexahydroxy-2-oxo-7-[(2e,4e,6e)-pentadeca-2,4,6,14-tetraen-1-yl]-3h,3ah,6h,7h,10h,13h,16h,16ah-furo[3,2-l]1,4,7,11-tetraazacyclopentadecan-13-yl]propanimidic acid

C31H45N5O9 (631.3217)


   

4-(benzyloxy)-11-ethyl-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate

4-(benzyloxy)-11-ethyl-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate

C34H49NO10 (631.3356)